Company news
Alaunos Therapeutics, Inc. news in 2023
Alaunos Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
November 13, 2023
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
August 13, 2023
Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies
June 28, 2023
Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
June 12, 2023
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting
May 24, 2023
Alaunos Therapeutics Reports First Quarter 2023 Financial Results
May 9, 2023
Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023
May 2, 2023
Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
April 25, 2023
Entry into a Material Definitive Agreement (form 8-K)
April 3, 2023
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors
March 29, 2023
Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
March 6, 2023
Calls in 2023
Decks in 2023
- Investor Presentation (July 2023)
Investor deck · 21 slides · July 2023
- Investor Presentation (April 2023)
Investor deck · 21 slides · April 2023
- Investor Presentation (January 2023)
Investor deck · 21 slides · January 2023